Biotech · Private company
BioDelivery Sciences International
Track this companyFree. Adds BioDelivery Sciences International to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- BEMA™Phase 3 · PainClinicalTrials.gov · fetched Nov 12, 2026
- DFN-15 ActivePhase 3 · Migraine HeadacheClinicalTrials.gov · fetched Nov 12, 2026
- Belbuca 300 µgPhase 1 · Respiratory DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Belbuca 600 µgPhase 1 · Respiratory DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Belbuca 900 µgPhase 1 · Respiratory DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Oxycodone 30 mgPhase 1 · Respiratory DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Oxycodone 60 mgPhase 1 · Respiratory DepressionClinicalTrials.gov · fetched Nov 12, 2026
- LubiprostoneOpioid-induced ConstipationClinicalTrials.gov · fetched Nov 12, 2026
- NaldemedineOpioid-induced ConstipationClinicalTrials.gov · fetched Nov 12, 2026
- NaloxegolOpioid-induced ConstipationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- True Functional Restoration and Analgesia in Non-Radicular Low Back PainPHASE4 · UNKNOWN · started Aug 3, 2022ClinicalTrials.gov NCT05419297 · fetched Nov 12, 2026
- Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo.PHASE1 · COMPLETED · started Jul 23, 2019ClinicalTrials.gov NCT03996694 · fetched Nov 12, 2026
- Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced ConstipationRECRUITING · started Jan 4, 2019ClinicalTrials.gov NCT03720613 · fetched Nov 12, 2026
- Efficacy, Tolerability, and Safety Study of DFN-15PHASE3 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT03006276 · fetched Nov 12, 2026
- Efficacy, Tolerability, and Safety of DFN-15PHASE3 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT03009019 · fetched Nov 12, 2026
- Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer SubjectsPHASE3 · COMPLETED · started Feb 1, 2006ClinicalTrials.gov NCT00293033 · fetched Nov 12, 2026